Response‐adapted therapy for aggressive non‐Hodgkin's lymphomas based on early [18F] FDG‐PET scanning: ECOG‐ACRIN Cancer Research Group study (E3404)

Publisher： John Wiley & Sons Inc

E-ISSN： 1365-2141|170|1|56-65

ISSN： 0007-1048

Source： BRITISH JOURNAL OF HAEMATOLOGY, Vol.170, Iss.1, 2015-07, pp. : 56-65

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Randomized phase 3 study in low‐grade lymphoma comparing maintenance anti‐CD20 antibody with observation after induction therapy: A trial of the ECOG‐ACRIN Cancer Research Group (E1496)

By  

CANCER, Vol. 122, Iss. 19, 2016-10 ,pp. : 2996-3004

John Wiley & Sons Inc

Access to resources Recommend Favorite

Phase 2 study of treatment selection based on tumor thymidylate synthase expression in previously untreated patients with metastatic colorectal cancer: A trial of the ECOG‐ACRIN Cancer Research Group (E4203)

By  

CANCER, Vol. 124, Iss. 4, 2018-02 ,pp. : 688-697

John Wiley & Sons Inc

Access to resources Recommend Favorite

Therapy response monitoring of the early effects of a new BRAF inhibitor on melanoma xenograft in mice: evaluation of 18F‐FDG‐PET and 18F‐FLT‐PET

By  

CONTRAST MEDIA & MOLECULAR IMAGING (ELECTRONIC), Vol. 10, Iss. 3, 2015-05 ,pp. : 203-210

John Wiley & Sons Inc

Access to resources Recommend Favorite

Importance of F18-Fluorodeoxy-D-2-Glucose Positron Emission Tomography (FDG-PET) for Staging and Therapy Control of Hodgkin’s Lymphoma in Childhood and Adolescence – Consequences for the GPOH-HD 2003 Protocol

By  

Oncology Research and Treatment, Vol. 26, Iss. 5, 2003-11 ,pp. : 489-493

Karger

Access to resources Recommend Favorite

The Value of Radiation Therapy in the Management of Aggressive Non-Hodgkin’s Lymphomas

By  

Oncology Research and Treatment, Vol. 25, Iss. 3, 2002-07 ,pp. : 214-220

Karger

Access to resources Recommend Favorite